This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Oct;16(10):592.

doi: 10.1038/s41571-019-0261-x.

Deglycosylated PD-L1 might be a better biomarker

Peter Sidaway¹

Affiliations

PMID: 31388124
DOI: 10.1038/s41571-019-0261-x

Comment

Deglycosylated PD-L1 might be a better biomarker

Peter Sidaway. Nat Rev Clin Oncol. 2019 Oct.

. 2019 Oct;16(10):592.

doi: 10.1038/s41571-019-0261-x.

Author

Peter Sidaway¹

Affiliation

¹ Nature Reviews Clinical Oncology, . nrclinonc@nature.com.

PMID: 31388124
DOI: 10.1038/s41571-019-0261-x

No abstract available

PubMed Disclaimer

Comment on

Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy.
Lee HH, Wang YN, Xia W, Chen CH, Rau KM, Ye L, Wei Y, Chou CK, Wang SC, Yan M, Tu CY, Hsia TC, Chiang SF, Chao KSC, Wistuba II, Hsu JL, Hortobagyi GN, Hung MC. Lee HH, et al. Cancer Cell. 2019 Aug 12;36(2):168-178.e4. doi: 10.1016/j.ccell.2019.06.008. Epub 2019 Jul 18. Cancer Cell. 2019. PMID: 31327656 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Research Materials
- NCI CPTC Antibody Characterization Program